Second Consecutive Quarter of Year-Over-Year Revenue Growth driven by Commercial B2B Sales Net Loss Improved by $4.5 million and Adjusted EBITDA Improved by $2.4 million Year-Over-Year, Reflecting Operating Leverage from Cost Actions Proprietary Brand Penetration Increased 500 Basis Points Year-Over-Year to 37.0% of Cultivation and Gardening Revenue $41.1 million in Cash, Cash Equivalents, and Marketable Securities with no Debt Company Reaffirms 2026 Outlook: Revenue of $162 million to $168 million and Approximately Breakeven Adjusted EBITDA(1) DENVER, May 12, 2026 (GLOBE NEWSWIRE) — GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen,” or the “Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today...

IRVING, Texas, May 12, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchestrating mission-critical systems that enable hyper-automation and digital transformation, announced today that it will host a live conference call with the financial community on May 14, 2026 at 5:00 pm Eastern Time to discuss its first quarter 2026 financial results, accompanied by a live webcast. The press release announcing first quarter 2026 results will be issued after market close on May 14, 2026. Hosting the call will be Andrej Jonovic, Chief Executive Officer, Dejan Avramovic, Chief Financial Officer, and Mike Shufeldt, Chief Revenue Officer. Participant Call-In Registration: Participants who wish to join the conference by telephone must register using...

First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected in 3Q 2026  Cash balance of $23.9 million as of March 31, 2026 anticipated to fund operations into 2027, including completion of the dose escalation portion of the ongoing BDC-4182 Phase 1/2 studyREDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the first quarter ended March 31, 2026, and provided a business update. “We are encouraged by what we have seen thus far in patients treated with BDC-4182, a next-generation Boltbody™ ISAC. BDC-4182 has a unique mechanism of action that has the potential to combine the power of ADCs...

CBeyond™ Expansion Study (Part C) initiated; Cohort Review Committee review scheduled for May 18, 2026, to evaluate available safety data and potential progression to Cohort 2SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related conditions, today reported financial results for the first quarter ended March 31, 2026, along with recent business updates and anticipated milestones. “Since our March update, execution has focused on turning CBeyond into a Phase 2b-ready development program,” said Punit Dhillon, President & CEO of Skye. “We have now initiated enrollment of Cohort 1 of the CBeyond Expansion Study,...

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)12 May 2026 –  Theon International Plc (THEON)  would like to notify market participants that the Q1 2026 Trading Update Report published on its website on 5 May 2026 has been revised on the Cash Flow Statement (page 15) to reflect a reclassification of the profit from financial assets measured at fair value to a non-cash item within the cash flow statement. This reclassification has no impact on the Company’s reported net debt position or any other details within the Q1 2026 Trading Update published via Euronext Amsterdam. The corrected Q1 2026 Trading Update is available on the Company’s website.For inquiries, please contact:Investor RelationsNikos MalesiotisE-Mail: ir@theon.comTel: +30 210 6772290 Media ContactElli MichouE-Mail: press@theon.comTel: +30 210...

Coface posts a good start to the year, recording net profit of €53.6m; annualised RoATE at 11.0% Paris, 12 May 2026 – 5.35 p.m.Turnover: €465m, stable at constant FX and perimeterInsurance revenue was down by -1.3% at constant FX. Client activity was up +0.7%, lower than the historical average Client retention approaching record highs (94.8%). Pricing was down (-1.1%), but lower than in previous years Revenue from non-insurance activities (factoring, business information and debt collection) rose by +9.2% at €43.9m. Double-digit growth from business information continued (+11.8% at constant FX and +17.7% on a reported basis). Debt collection was up by +31.6%, and factoring rose by +2.2%Net loss ratio at 37.6%, improved by 1.6 ppt. Net combined ratio at 70.0%Gross loss ratio at 36.3%, improved by 2.4 ppts, with still high opening...

Robust growth in net interest income alongside a reduction in operating expenses. At a board meeting on 12 May 2026, the Board of Directors and the CEO approved the condensed interim consolidated financial statements of Kvika banki hf. (“Kvika” or “the bank”) for the first quarter of 2026. Highlights of performance in the first quarter (Q1 2026):Profit before tax from continuing operations amounts to ISK 1,809 million in Q1 2026, compared to ISK 701 million in Q1 2025, increasing by ISK 1,108 million from previous year or 158%. Post-tax profit from continuing operations of the Kvika group amounts to ISK 1,374 million in Q1 2026, compared to ISK 186 million in Q1 2025, increasing by ISK 1,188 million from previous year. Net interest income amounts to ISK 3,266 million in Q1 2026, compared to ISK 2,917 million in Q1 2025, increasing by...

JEFFERSONVILLE, N.Y., May 12, 2026 (GLOBE NEWSWIRE) — Jeffersonville Bancorp, Inc. (OTCQB – JFBC) announced today first quarter net income of $3,282,000 or $0.77 per share compared to $2,718,000 or $0.64 per share for the same quarter in 2025. The increase in quarterly net income compared to 2025 of $564,000 was primarily attributable to an increase in loan interest and fees of $495,000, an increase in securities income of $222,000, and a decrease in the credit loss provision of $239,000. These improvements were partially offset by a decrease in other interest and dividend income of $187,000 and an increase in tax expense of $171,000. “Earnings momentum from 2025 continued in the first quarter of 2026 with continued loan growth, higher rates on investment securities, and low core deposit expense,” said George...

MIAMI, May 12, 2026 (GLOBE NEWSWIRE) — Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, today announces compelling financial and operational results through the first quarter of 2026, highlighting the Company’s strategic growth in their receivables portfolio, net income, earnings per share (EPS), loan originations and return on equity. “Our unprecedented results reinforce our disciplined approach to premium finance and how we create real, lasting value for shareholders,” says William Koppelmann, CEO, Standard Premium. “Building upon this exceptional performance, we continue to find opportunities to provide dynamic growth beyond our core business model.” Key financial highlights include:Return on equity of 21.90% maintains consistent double digit return on equity. 21.5%...

Announcement no. 9-2026 12 May 2026   Martin Frandsen Tobberup, Group Executive Director and CDO, on the Group’s performance in Q1 2026: ” We delivered an improved operating result, which was positively impacted by both business areas, especially in Last Mile, where FK Distribution in particular managed to reduce the costs related to distribution and administration. In Digital Services, the progress was due to Dayli and Bekey, while BoligPortal had a challenging Q1 2026.”         Financial highlights:DKKm                     Q1  2026 2025Revenue 293.7 310.5EBITDA 19.0 10.6EBIT 4.3 -1.4EBIT margin (%) 1.5% -0.5%Return on securities -39.7 -151.7Cash flows from operating activities -8.6 -23.0Free cash flows 17.0 -35.4Business area performance in Q1 2026 Last Mile (FK Distribution and SDR) delivered revenue of...